Mitochondrial Matters of the Brain: Role in Parkinson Disease
465-467
Mitochondrial matters in Parkinson disease: introduction
George H. Sack
469-472
The role of dopamine oxidation in mitochondrial dysfunction: implications for Parkinson’s disease
Teresa G. Hastings
473-479
Mitochondrial quality control: insights on how Parkinson’s disease related genes PINK1, parkin, and Omi/HtrA2 interact to maintain mitochondrial homeostasis
Ruben K. Dagda and Charleen T. Chu
481-486
Open AccessThe mitochondrial kinase PINK1, stress response and Parkinson’s disease
Marina Jendrach, Suzana Gispert, Filomena Ricciardi, Michael Klinkenberg and Rudolf Schemm, et al.
487-491
Open AccessMitochondrial dysfunction in mouse models of Parkinson’s disease revealed by transcriptomics and proteomics
Desmond J. Smith
493-497
Parkinson’s disease and mitochondrial complex I: a perspective on the Ndi1 therapy
Mathieu Marella, Byoung Boo Seo, Takao Yagi and Akemi Matsuno-Yagi
499-503
The PINK1/Parkin pathway: a mitochondrial quality control system?
Alexander J. Whitworth and Leo J. Pallanck
505-508
PET studies of cerebral metabolism in Parkinson Disease
William J. Powers
509-516
Mitochondrial respiratory dysfunction and mutations in mitochondrial DNA in PINK1 familial Parkinsonism
Sergio Papa, Anna Maria Sardanelli, Nazzareno Capitanio and Claudia Piccoli
517-521
Brain mitochondrial dysfunction and oxidative damage in Parkinson’s disease
Ana Navarro and Alberto Boveris